Skip to main content
logo
Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
79.55
-2.41 (-2.94%)
Mar 3, 2026, 2:51 PM EST - Market open

Ionis Pharmaceuticals Revenue by Segment

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Research and Development
507.74M586.74M603.82M407.74M412.20M517.20M519.24M476.54M
Research and Development Growth
23.18%13.44%16.29%-14.44%-14.02%69.35%56.10%71.59%
Commercial
435.92M380.92M340.66M309.94M293.36M286.36M294.71M300.57M
Commercial Growth
48.60%33.02%15.59%3.12%-4.98%-7.55%-1.13%0.74%

Revenue by Product

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Spinraza
222.35M223.56M225.96M216.41M214.41M224.45M228.72M240.51M
Spinraza Growth
3.70%-0.40%-1.21%-10.02%-12.67%-6.44%-4.11%-0.65%
Wainua
42.79M35.16M28.52M20.28M----------------
Tegsedi and Waylivra
35.25M36.17M30.83M33.74M34.74M34.11M36.57M34.42M
Tegsedi and Waylivra Growth
1.44%6.05%-15.69%-1.96%7.17%13.49%22.78%16.81%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.